Phase III clinical trials are a critical stage in cancer research. These trials are designed to compare the new treatment against the current standard treatment. The goal is to determine if the new treatment provides a better outcome for patients. Phase III trials involve a larger number of participants, typically ranging from hundreds to thousands, to ensure the results are statistically significant and can be generalized to the wider population.
